The World Health Organization voiced hope Tuesday the number of Ebola cases would start falling sharply early next year, stressing the need to develop rapid diagnostic tests for the end-phase.
A team of researchers from Inserm led by Paul Hofman (Inserm Unit 1081/University of Nice) has just made a significant advance in the area of early diagnosis of invasive cancers. In a study which has just ...
Swiss pharmaceutical group Roche hopes to obtain fast-track US approval for a rapid diagnostic test for Ebola, its director general said in an interview published Sunday, amid the worst-ever outbreak of the killer disease.
(HealthDay)—Two protein markers may serve as biomarkers for chronic rhinosinusitis, according to a proof-of-principle study published in The Laryngoscope.